3
|
Wolf BJ, Tatituri RVV, Almeida CF, Le Nours J, Bhowruth V, Johnson D, Uldrich AP, Hsu FF, Brigl M, Besra GS, Rossjohn J, Godfrey DI, Brenner MB. Identification of a Potent Microbial Lipid Antigen for Diverse NKT Cells. THE JOURNAL OF IMMUNOLOGY 2015; 195:2540-51. [PMID: 26254340 DOI: 10.4049/jimmunol.1501019] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/04/2015] [Accepted: 07/10/2015] [Indexed: 01/17/2023]
Abstract
Semi-invariant/type I NKT cells are a well-characterized CD1d-restricted T cell subset. The availability of potent Ags and tetramers for semi-invariant/type I NKT cells allowed this population to be extensively studied and revealed their central roles in infection, autoimmunity, and tumor immunity. In contrast, diverse/type II NKT (dNKT) cells are poorly understood because the lipid Ags that they recognize are largely unknown. We sought to identify dNKT cell lipid Ag(s) by interrogating a panel of dNKT mouse cell hybridomas with lipid extracts from the pathogen Listeria monocytogenes. We identified Listeria phosphatidylglycerol as a microbial Ag that was significantly more potent than a previously characterized dNKT cell Ag, mammalian phosphatidylglycerol. Further, although mammalian phosphatidylglycerol-loaded CD1d tetramers did not stain dNKT cells, the Listeria-derived phosphatidylglycerol-loaded tetramers did. The structure of Listeria phosphatidylglycerol was distinct from mammalian phosphatidylglycerol because it contained shorter, fully-saturated anteiso fatty acid lipid tails. CD1d-binding lipid-displacement studies revealed that the microbial phosphatidylglycerol Ag binds significantly better to CD1d than do counterparts with the same headgroup. These data reveal a highly potent microbial lipid Ag for a subset of dNKT cells and provide an explanation for its increased Ag potency compared with the mammalian counterpart.
Collapse
Affiliation(s)
- Benjamin J Wolf
- Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
| | - Raju V V Tatituri
- Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
| | - Catarina F Almeida
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging at University of Melbourne, Parkville, Victoria 3010, Australia
| | - Jérôme Le Nours
- Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia
| | - Veemal Bhowruth
- School of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
| | - Darryl Johnson
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging at University of Melbourne, Parkville, Victoria 3010, Australia
| | - Adam P Uldrich
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging at University of Melbourne, Parkville, Victoria 3010, Australia
| | - Fong-Fu Hsu
- Division of Endocrinology, Metabolism, and Lipid Research, Washington University, St. Louis, MO 63110
| | - Manfred Brigl
- Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; and
| | - Gurdyal S Besra
- School of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom
| | - Jamie Rossjohn
- Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom
| | - Dale I Godfrey
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria 3010, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging at University of Melbourne, Parkville, Victoria 3010, Australia
| | - Michael B Brenner
- Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115;
| |
Collapse
|
10
|
Anand S, Wang P, Yoshimura K, Choi IH, Hilliard A, Chen YH, Wang CR, Schulick R, Flies AS, Flies DB, Zhu G, Xu Y, Pardoll DM, Chen L, Tamada K. Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J Clin Invest 2006; 116:1045-51. [PMID: 16557300 PMCID: PMC1409742 DOI: 10.1172/jci27083] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2005] [Accepted: 01/31/2006] [Indexed: 12/21/2022] Open
Abstract
LIGHT is an important costimulatory molecule for T cell immunity. Recent studies have further implicated its role in innate immunity and inflammatory diseases, but its cellular and molecular mechanisms remain elusive. We report here that LIGHT is upregulated and functions as a proinflammatory cytokine in 2 independent experimental hepatitis models, induced by concanavalin A and Listeria monocytogenes. Molecular mutagenesis studies suggest that soluble LIGHT protein produced by cleavage from the cell membrane plays an important role in this effect through the interaction with the lymphotoxin-beta receptor (LTbetaR) but not herpes virus entry mediator. NK1.1+ T cells contribute to the production, but not the cleavage or effector functions, of soluble LIGHT. Importantly, treatment with a mAb that specifically interferes with the LIGHT-LTbetaR interaction protects mice from lethal hepatitis. Our studies thus identify a what we believe to be a novel function of soluble LIGHT in vivo and offer a potential target for therapeutic interventions in hepatic inflammatory diseases.
Collapse
MESH Headings
- Animals
- Antigens, Ly
- Antigens, Surface/metabolism
- Concanavalin A/metabolism
- Concanavalin A/pharmacology
- Cytokines/metabolism
- Hepatitis/etiology
- Hepatitis/metabolism
- Inflammation/metabolism
- Lectins, C-Type/metabolism
- Listeria monocytogenes/metabolism
- Listeria monocytogenes/pathogenicity
- Lymphotoxin beta Receptor
- Membrane Proteins/genetics
- Membrane Proteins/immunology
- Membrane Proteins/metabolism
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- NK Cell Lectin-Like Receptor Subfamily B
- Receptors, Tumor Necrosis Factor/immunology
- Receptors, Tumor Necrosis Factor/metabolism
- Receptors, Tumor Necrosis Factor, Member 14
- Receptors, Virus/immunology
- Receptors, Virus/metabolism
- Solubility
- Tumor Necrosis Factor Ligand Superfamily Member 14
- Tumor Necrosis Factor-alpha/genetics
- Tumor Necrosis Factor-alpha/immunology
- Tumor Necrosis Factor-alpha/metabolism
Collapse
Affiliation(s)
- Sudarshan Anand
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Pu Wang
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Kiyoshi Yoshimura
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - In-Hak Choi
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Anja Hilliard
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Youhai H. Chen
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Chyung-Ru Wang
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Richard Schulick
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Andrew S. Flies
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Dallas B. Flies
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Gefeng Zhu
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Yanhui Xu
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Drew M. Pardoll
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Lieping Chen
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Koji Tamada
- Immunology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Microbiology, Inje University College of Medicine, Pusan, Republic of Korea.
Committee on Immunology and Department of Pathology, University of Chicago, Chicago, Illinois, USA.
Department of Surgery and
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Biochemistry Graduate Program, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| |
Collapse
|